139 related articles for article (PubMed ID: 20733118)
21. The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and Migration.
Nguyen HD; Liao YC; Ho YS; Chen LC; Chang HW; Cheng TC; Liu D; Lee WR; Shen SC; Wu CH; Tu SH
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835799
[TBL] [Abstract][Full Text] [Related]
22. Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model.
Huang LC; Lin CL; Qiu JZ; Lin CY; Hsu KW; Tam KW; Lee JY; Yang JM; Lee CH
Front Cell Neurosci; 2017; 11():336. PubMed ID: 29163048
[TBL] [Abstract][Full Text] [Related]
23. Nitrosamines crisis in pharmaceuticals - Insights on toxicological implications, root causes and risk assessment: A systematic review.
Vikram HPR; Kumar TP; Kumar G; Beeraka NM; Deka R; Suhail SM; Jat S; Bannimath N; Padmanabhan G; Chandan RS; Kumar P; Gurupadayya B
J Pharm Anal; 2024 May; 14(5):100919. PubMed ID: 38799236
[TBL] [Abstract][Full Text] [Related]
24. Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.
Lee CH; Hsu KW; Hsieh YY; Li WT; Long Y; Lin CY; Chen SH
Cells; 2024 Apr; 13(7):. PubMed ID: 38607055
[TBL] [Abstract][Full Text] [Related]
25. CHRNA9 as a New Prognostic Marker and Potential Therapeutic Target in Glioma.
Ma X; Geng R; Zhao Y; Xu W; Li Y; Jiang Y; Liu Y; Zhao L; Li Y
J Cancer; 2024; 15(8):2095-2109. PubMed ID: 38495483
[No Abstract] [Full Text] [Related]
26. Cell signaling and epigenetic regulation of nicotine-induced carcinogenesis.
Sun Q; Jin C
Environ Pollut; 2024 Mar; 345():123426. PubMed ID: 38295934
[TBL] [Abstract][Full Text] [Related]
27. A systematic review of preclinical studies evaluating the association between nicotine and the initiation and progression of cancer.
Kim MM; Steffensen I; Miguel RTD; Babic T; Johnson AD; Potts R; Junker CS
Ann Transl Med; 2023 Dec; 11(12):410. PubMed ID: 38213798
[TBL] [Abstract][Full Text] [Related]
28. Inflammation-Related Immune-Modulatory SLURP1 Prevents the Proliferation of Human Colon Cancer Cells, and Its Delivery by
Senevirathne A; Aganja RP; Hewawaduge C; Lee JH
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896222
[TBL] [Abstract][Full Text] [Related]
29. Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers.
Liao YC; Cheng TC; Tu SH; Chang J; Guo P; Chen LC; Ho YS
Mol Ther Nucleic Acids; 2023 Sep; 33():351-366. PubMed ID: 37547295
[TBL] [Abstract][Full Text] [Related]
30. α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling.
Oz M; King JR; Yang KS; Khushaish S; Tchugunova Y; Khajah MA; Luqmani YA; Kabbani N
PLoS One; 2023; 18(7):e0289098. PubMed ID: 37490473
[TBL] [Abstract][Full Text] [Related]
31. Exploring neurotransmitters and their receptors for breast cancer prevention and treatment.
Li RQ; Zhao XH; Zhu Q; Liu T; Hondermarck H; Thorne RF; Zhang XD; Gao JN
Theranostics; 2023; 13(3):1109-1129. PubMed ID: 36793869
[TBL] [Abstract][Full Text] [Related]
32.
Margiotta F; Micheli L; Ciampi C; Ghelardini C; McIntosh JM; Di Cesare Mannelli L
Mar Drugs; 2022 Dec; 20(12):. PubMed ID: 36547920
[No Abstract] [Full Text] [Related]
33. Alkaloid ligands enable function of homomeric human α10 nicotinic acetylcholine receptors.
Hone AJ; McIntosh JM
Front Pharmacol; 2022; 13():981760. PubMed ID: 36188578
[TBL] [Abstract][Full Text] [Related]
34. Curcumin-induced antitumor effects on triple-negative breast cancer patient-derived xenograft tumor mice through inhibiting salt-induced kinase-3 protein.
Cheng TC; Sayseng JO; Tu SH; Juan TC; Fang CL; Liao YC; Chu CY; Chang HW; Yen Y; Chen LC; Ho YS
J Food Drug Anal; 2021 Dec; 29(4):622-637. PubMed ID: 35649138
[TBL] [Abstract][Full Text] [Related]
35. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy.
Khodabandeh Z; Valilo M; Velaei K; Pirpour Tazehkand A
Breast Cancer; 2022 Sep; 29(5):778-789. PubMed ID: 35583594
[TBL] [Abstract][Full Text] [Related]
36. Corticofugal and Brainstem Functions Associated With Medial Olivocochlear Cholinergic Transmission.
Munoz F; Vicencio-Jimenez S; Jorratt P; Delano PH; Terreros G
Front Neurosci; 2022; 16():866161. PubMed ID: 35573302
[TBL] [Abstract][Full Text] [Related]
37. Advances in understanding cancer-associated neurogenesis and its implications on the neuroimmune axis in cancer.
Yaman I; Ağaç Çobanoğlu D; Xie T; Ye Y; Amit M
Pharmacol Ther; 2022 Nov; 239():108199. PubMed ID: 35490859
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-mediated knockout of VEGFR2/KDR inhibits cell growth in a squamous thyroid cancer cell line.
Tsai ML; Lee CH; Huang LC; Chen YH; Liu WN; Lin CY; Hsu KW; Lee AW; Lin CL
FEBS Open Bio; 2022 May; 12(5):993-1005. PubMed ID: 35313079
[TBL] [Abstract][Full Text] [Related]
39. Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression.
Wang J; Li D; Zhao B; Kim J; Sui G; Shi J
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269825
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
